KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

J. Goldman & Co LP's Holding History (CIK: 0001412741)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 54,236 Value ($000) $3,149 Avg Close $49.39 Range $40.93 - $59.06

Q2 2024

Shares 30,102 Value ($000) $1,376 Avg Close $53.73 Range $43.30 - $67.30

Q4 2023

Shares 5,802 Value ($000) $231 Avg Close $31.36 Range $27.02 - $41.92

Q2 2023

Shares 7,677 Value ($000) $308 Avg Close $43.84 Range $37.03 - $51.16

Q1 2023

Shares 7,322 Value ($000) $313 Avg Close $50.51 Range $39.98 - $59.96

Q4 2022

Shares 24,281 Value ($000) $1,166 Avg Close $46.71 Range $37.40 - $52.78

Q3 2022

Shares 8,416 Value ($000) $317 Avg Close $34.66 Range $26.34 - $42.15

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	54,236	$3,149	$49.39	$40.93 - $59.06
Q2 2024	30,102	$1,376	$53.73	$43.30 - $67.30
Q4 2023	5,802	$231	$31.36	$27.02 - $41.92
Q2 2023	7,677	$308	$43.84	$37.03 - $51.16
Q1 2023	7,322	$313	$50.51	$39.98 - $59.96
Q4 2022	24,281	$1,166	$46.71	$37.40 - $52.78
Q3 2022	8,416	$317	$34.66	$26.34 - $42.15